Calidi Biotherapeutics, Inc.

Biotechnology • Healthcare • San Diego, CA, United States • CLDWW (PNK)

Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, develops allogeneic stem cell-based and enveloped virus platforms to potentiate and deliver oncolytic viruses in the United States. Its product pipeline comprises CLD-101, which is in Phase 1b/2 clinical trial for the treatment of high-grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck squamous cell carcinoma, and soft tissue sarcoma, which is in pre-clinical studies; CLD-301 for multiple indications, which is in preclinical studies; and CLD-400 for certain lung cancer and metastatic solid tumors. The company also offers oncolytic virus platforms, such as NeuroNova, SuperNova, and RTNova. Calidi Biotherapeutics, Inc. was founded in 2014 and is headquartered in San Diego, California.

858 794 9600 4475 Executive Drive, San Diego, CA 92121, United States

Stock Performance (90 Days)

Data through Oct 15, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Will Calidi Biotherapeutics Inc. stock outperform international peers - Earnings Miss Alerts & Affordable Trading Portfolio - bollywoodhelpline.com

bollywoodhelpline.com • Dec 29

Calidi (NYSE American: CLDI) closes $6.9M offering; third-quarter net loss $5.2M - Stock Titan

Stock Titan • Nov 13

Calidi Biotherapeutics Announces New Data to be Presented on its Therapeutic Lead, CLD-401, at the 2025 SITC Annual Meeting - Yahoo Finance

Yahoo Finance • Oct 30

Why Is Calidi Biotherapeutics Stock (CLDI) Up 170% Today? - TipRanks

TipRanks • Jul 9

Calidi Biotherapeutics Announces 1-for-12 Reverse Stock Split to Enhance Market Appeal | CLDI Stock News - Quiver Quantitative

Quiver Quantitative • Jul 25

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Calidi Biotherapeutics, Inc. had layoffs?

No layoff events have been recorded for Calidi Biotherapeutics, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Calidi Biotherapeutics, Inc. have?

Calidi Biotherapeutics, Inc. has approximately 28 employees.

What industry is Calidi Biotherapeutics, Inc. in?

Calidi Biotherapeutics, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Calidi Biotherapeutics, Inc. a publicly traded company?

Yes, Calidi Biotherapeutics, Inc. is publicly traded under the ticker symbol CLDWW on the PNK.

Where is Calidi Biotherapeutics, Inc. headquartered?

Calidi Biotherapeutics, Inc. is headquartered in San Diego, CA, United States at 4475 Executive Drive, San Diego, CA 92121, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.